TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

BACKGROUND: The molecular determinants of clinical responses to decitabine therapy in patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) are unclear. METHODS: We enrolled 84 adult patients with AML or MDS in a single-institution trial of decitabine to identify somatic muta...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:N Engl J Med
Huvudupphovsmän: Welch, John S., Petti, Allegra A., Miller, Christopher A., Fronick, Catrina C., O'Laughlin, Michelle, Fulton, Robert S., Wilson, Richard K., Baty, Jack D., Duncavage, Eric J., Tandon, Bevan, Lee, Yi-Shan, Wartman, Lukas D., Uy, Geoffrey L., Ghobadi, Armin, Tomasson, Michael H., Pusic, Iskra, Romee, Rizwan, Fehniger, Todd A., Stockerl-Goldstein, Keith E., Vij, Ravi, Oh, Stephen T., Abboud, Camille N., Cashen, Amanda F., Schroeder, Mark A., Jacoby, Meagan A., Heath, Sharon E., Luber, Kierstin, Janke, Megan R., Hantel, Andrew, Khan, Niloufer, Sukhanova, Madina J., Knoebel, Randall W., Stock, Wendy, Graubert, Timothy A., Walter, Matthew J., Westervelt, Peter, Link, Daniel C., DiPersio, John F., Ley, Timothy J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217532/
https://ncbi.nlm.nih.gov/pubmed/27959731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1605949
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk